Keywords: ucb, keppra, launch, plans, following, european, union

UCB's Keppra launch plans following European Union approval

Article | 19 October 2000

Print This

UCB's anti-epilepsy treatment Keppra (levetiracetam) will becomeavailable next month in the UK and Germany as an adjunctive therapy in the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in